伤口愈合
表皮(动物学)
免疫染色
真皮
皮肤当量
下调和上调
化学
体外
病理
生物医学工程
医学
角质形成细胞
免疫组织化学
外科
解剖
基因
生物化学
作者
Chunyan He,Wei Zhang,Yidong Tu,Lingyan Zhong,Ranran Wang,Yao Teng,I‐Chien Liao,Chunmei Ding
摘要
Abstract Objective This study describes the development and characterization of a novel in vitro wound‐healing model based on a full‐thickness reconstructed skin by exposing the tissue to fractional ablative laser treatment. Method A 3D full‐thickness skin model was fabricated and treated with fractional ablative CO 2 laser. Wound‐healing process was characterized by HE staining, noninvasive OCT imaging, immunostaining, as well as transepidermal water loss measurement. Cytokines and proteins involved in the inflammatory and dermal remodeling process were studied by ELISA and protein array assays. Results Fractional ablative CO 2 treatment induced a wound zone of 9 mm in diameter, containing 56 micro‐wounds with 200 μm diameter and 500–700 μm in depth on reconstructed full‐thickness skin model. HE staining revealed a typical wound morphology and healing process with migration of keratinocytes, formation and extrusion of necrotic tissue, and cell inclusion in dermis, which correlates with clinical observations. Based on OCT and TEWL measurements, the re‐epithelialization took place over 2 days. Laser‐triggered keratinocytes proliferation and differentiation were demonstrated by activated Ki67 and Filaggrin expression respectively. Injury‐invoked cytokine ICAM‐1 showed instant upregulation on Day 1. Decreased epidermis thickness and depression of IGFBP‐2 protein level synergistically indicated the unavoidable thermal side effects from laser treatment. Downregulated DKK‐1 protein level and upregulation of α‐SMA together implicated the risk of potential fibrosis post‐laser treatment. Conclusion This in vitro laser wounded reconstructed skin model captured the key events of wound‐healing process, could be used to investigate the mechanisms of wound‐healing triggered by a commonly used beauty procedure, and also provides a valuable tool for evaluating the efficacy of novel actives for the post‐procedure application.
科研通智能强力驱动
Strongly Powered by AbleSci AI